Application of the ATP-cell viability assay for assessment of in vitro radiation treatment response in gynecologic cancer cell lines.
Rodriguez
M
M
Division of Gynecologic Oncology (D-52), University of Miami School of Medicine, Fla.
Steren
A J
AJ
D000255:Adenosine Triphosphate; D000818:Animals; D002470:Cell Survival; D003131:Combined Modality Therapy; D006224:Cricetinae; D003412:Cricetulus; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D004307:Dose-Response Relationship, Radiation; D004354:Drug Screening Assays, Antitumor / Q000379:methods*; D005260:Female; D010051:Ovarian Neoplasms / Q000473:pathology* / Q000532:radiotherapy*; D017239:Paclitaxel / Q000627:therapeutic use*; D011836:Radiation Tolerance; D011879:Radiotherapy Dosage; D014407:Tumor Cells, Cultured; D002583:Uterine Cervical Neoplasms / Q000473:pathology* / Q000532:radiotherapy*
D000255:Adenosine Triphosphate; D017239:Paclitaxel